Alpa Laboratories Limited

Alpa Laboratories Limited (ALPA) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

alpalabs.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹63.30
Market cap
133 Cr
Stock P/E
25.2
P/B
0.71

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales32 Cr27 Cr24 Cr21 Cr25 Cr26 Cr40 Cr19 Cr26 Cr29 Cr31 Cr24 Cr
Operating expenses (approx.)29 Cr25 Cr20 Cr21 Cr22 Cr25 Cr40 Cr19 Cr28 Cr28 Cr28 Cr28 Cr
EBITDA3 Cr2 Cr4 Cr0.53 Cr3 Cr0.74 Cr0.20 Cr0.42 Cr-2 Cr2 Cr4 Cr-4 Cr
OPM %10.4%8.9%14.9%2.5%13.3%2.8%0.5%2.2%-8.5%5.2%11.5%-16.5%
Other income3 Cr4 Cr4 Cr5 Cr7 Cr9 Cr2 Cr12 Cr3 Cr0.91 Cr-0.16 Cr6 Cr
Interest0.02 Cr0.02 Cr0.29 Cr0.05 Cr0.05 Cr0.09 Cr0.02 Cr0.05 Cr0.03 Cr0.03 Cr0.15 Cr0.11 Cr
Depreciation0.49 Cr0.66 Cr0.52 Cr0.54 Cr0.53 Cr0.55 Cr0.58 Cr0.55 Cr0.67 Cr0.65 Cr0.22 Cr0.72 Cr
Profit before tax6 Cr5 Cr7 Cr5 Cr10 Cr9 Cr2 Cr12 Cr0.11 Cr2 Cr2 Cr0.98 Cr
Tax %0.0%14.9%46.7%0.0%20.4%0.0%202.4%0.0%0.0%-8.9%77.2%0.0%
Net profit6 Cr5 Cr4 Cr5 Cr8 Cr9 Cr-2 Cr12 Cr0.11 Cr2 Cr0.50 Cr0.98 Cr
EPS (₹)₹2.75₹2.17₹1.71₹2.42₹3.66₹4.23₹-0.95₹5.59₹0.05₹0.90₹0.24₹0.49

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales86 Cr98 Cr112 Cr92 Cr109 Cr112 Cr106 CrSign in for TTM
Operating expenses (approx.)83 Cr90 Cr102 Cr85 Cr101 Cr108 Cr103 CrSign in for TTM
EBITDA3 Cr8 Cr11 Cr8 Cr8 Cr5 Cr3 CrSign in for TTM
OPM %3.9%7.9%9.5%8.2%7.5%4.2%3.1%Sign in for TTM
Other income3 Cr4 Cr11 Cr10 Cr15 Cr23 Cr16 CrSign in for TTM
Interest0.20 Cr0.08 Cr0.24 Cr0.22 Cr0.36 Cr0.23 Cr0.26 CrSign in for TTM
Depreciation3 Cr1 Cr2 Cr1 Cr2 Cr2 Cr2 CrSign in for TTM
Profit before tax3 Cr11 Cr20 Cr16 Cr21 Cr26 Cr16 CrSign in for TTM
Tax %36.3%32.8%28.0%20.7%18.9%24.0%10.7%Sign in for TTM
Net profit2 Cr7 Cr14 Cr13 Cr17 Cr20 Cr14 CrSign in for TTM
EPS (₹)₹0.89₹3.45₹6.67₹5.90₹8.01₹9.34₹6.71Sign in for TTM
Dividend payout %——0.0%0.0%0.0%0.0%0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital21 Cr21 Cr21 Cr21 Cr21 Cr21 Cr21 Cr
Reserves79 Cr87 Cr101 Cr114 Cr131 Cr150 Cr165 Cr
Borrowings0.19 Cr0.0091 Cr6 Cr2 Cr5 Cr—3 Cr
Other liabilities21 Cr33 Cr28 Cr31 Cr25 Cr51 Cr53 Cr
Total liabilities121 Cr140 Cr155 Cr167 Cr183 Cr223 Cr242 Cr
Fixed assets (net)6 Cr7 Cr9 Cr7 Cr11 Cr21 Cr20 Cr
CWIP0.81 Cr2 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Investments57 Cr51 Cr75 Cr78 Cr98 Cr118 Cr142 Cr
Loans & advances0.99 Cr0.77 Cr0.54 Cr0.56 Cr0.57 Cr0.54 Cr0.53 Cr
Inventories13 Cr17 Cr15 Cr13 Cr14 Cr18 Cr13 Cr
Trade receivables25 Cr35 Cr38 Cr47 Cr41 Cr47 Cr41 Cr
Cash & bank5 Cr2 Cr2 Cr9 Cr0.06 Cr0.03 Cr0.64 Cr
Other assets14 Cr26 Cr16 Cr13 Cr17 Cr19 Cr25 Cr
Total assets121 Cr140 Cr155 Cr167 Cr183 Cr223 Cr242 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity——2 Cr-5 Cr4 Cr7 Cr11 Cr
Cash from investing——-16 Cr1 Cr-13 Cr-1 Cr-12 Cr
Cash from financing——6 Cr-3 Cr3 Cr-5 Cr2 Cr
Net cash flow——-8 Cr-7 Cr-7 Cr0.48 Cr0.62 Cr
Free cash flow (OCF − Capex)——-0.21 Cr-6 Cr-3 Cr-4 Cr7 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %3.1%10.1%16.3%11.8%13.4%15.1%8.5%
ROE %1.9%0.0%0.0%0.0%11.0%0.0%7.6%
Debtor days104132123184139152140
Inventory days931118984799177
Days payable101166861006896102
Cash conversion cycle9677127168150146115
Debt / equity0.00190.000.000.020.03—0.01
Current ratio4.593.704.424.985.694.104.01
Net debt / EBITDA0.000.000.00-0.860.64-0.00560.57

Compare with peers

Loading peers…